Literature DB >> 28987461

Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

Javier Blesa1, Inés Trigo-Damas2, Michele Dileone2, Natalia Lopez-Gonzalez Del Rey2, Ledia F Hernandez2, José A Obeso3.   

Abstract

The motor features of Parkinson's disease (PD) are well known to manifest only when striatal dopaminergic deficit reaches 60-70%. Thus, PD has a long pre-symptomatic and pre-motor evolution during which compensatory mechanisms take place to delay the clinical onset of disabling manifestations. Classic compensatory mechanisms have been attributed to changes and adjustments in the nigro-striatal system, such as increased neuronal activity in the substantia nigra pars compacta and enhanced dopamine synthesis and release in the striatum. However, it is not so clear currently that such changes occur early enough to account for the pre-symptomatic period. Other possible mechanisms relate to changes in basal ganglia and motor cortical circuits including the cerebellum. However, data from early PD patients are difficult to obtain as most studies have been carried out once the diagnosis and treatments have been established. Likewise, putative compensatory mechanisms taking place throughout disease evolution are nearly impossible to distinguish by themselves. Here, we review the evidence for the role of the best known and other possible compensatory mechanisms in PD. We also discuss the possibility that, although beneficial in practical terms, compensation could also play a deleterious role in disease progression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal Ganglia; Cerebellum; Circuits; Cortex; Dopamine; Parkinson disease; Striatum; Thalamus

Mesh:

Substances:

Year:  2017        PMID: 28987461     DOI: 10.1016/j.expneurol.2017.10.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  40 in total

1.  Dopaminergic modulation of motor network compensatory mechanisms in Parkinson's disease.

Authors:  Maya A Jastrzębowska; Renaud Marquis; Lester Melie-García; Antoine Lutti; Ferath Kherif; Michael H Herzog; Bogdan Draganski
Journal:  Hum Brain Mapp       Date:  2019-07-10       Impact factor: 5.038

2.  Levodopa treatment in Parkinson's disease: earlier or later?

Authors:  Federico Paolini Paoletti; Nicola Tambasco; Lucilla Parnetti
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Neurodegenerative diseases: model organisms, pathology and autophagy.

Authors:  S N Suresh; Vijaya Verma; Shruthi Sateesh; James P Clement; Ravi Manjithaya
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.

Authors:  Pablo Y Teruya; Fernando D Farfán; Álvaro G Pizá; Jorge H Soletta; Facundo A Lucianna; Ana L Albarracín
Journal:  Med Biol Eng Comput       Date:  2021-07-23       Impact factor: 2.602

Review 5.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

6.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28

7.  A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity.

Authors:  Lorena Cuenca-Bermejo; Elisa Pizzichini; Valeria C Gonçalves; María Guillén-Díaz; Elena Aguilar-Moñino; Consuelo Sánchez-Rodrigo; Ana-María González-Cuello; Emiliano Fernández-Villalba; María Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 8.  The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.

Authors:  Tamara Kobiec; Matilde Otero-Losada; Guenson Chevalier; Lucas Udovin; Sofía Bordet; Camila Menéndez-Maissonave; Francisco Capani; Santiago Pérez-Lloret
Journal:  Front Synaptic Neurosci       Date:  2021-04-22

9.  Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson's disease.

Authors:  Christina Andica; Koji Kamagata; Yuya Saito; Wataru Uchida; Shohei Fujita; Akifumi Hagiwara; Toshiaki Akashi; Akihiko Wada; Takashi Ogawa; Taku Hatano; Nobutaka Hattori; Shigeki Aoki
Journal:  NPJ Parkinsons Dis       Date:  2021-06-25

10.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.